Cited by 692Cancer, Hypoxia, and MetabolismAmino Acid Enzymes and MetabolismPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 18 sources its claims cite is checked for support yet.

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Open access

Abstract

The idea that conversion of glucose to ATP is an attractive target for cancer therapy has been supported in part by the observation that glucose deprivation induces apoptosis in rodent cells transduced with the proto-oncogene MYC, but not in the parental line. Here, we found that depletion of glucose killed normal human cells irrespective of induced MYC activity and by a mechanism different from apoptosis. However, depletion of glutamine, another major nutrient consumed by cancer cells, induced apoptosis depending on MYC activity. This apoptosis was preceded by depletion of the Krebs cycle intermediates, was prevented by two Krebs cycle substrates, but was unrelated to ATP synthesis or several other reported consequences of glutamine starvation. Our results suggest that the fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy, and that understanding how glutamine metabolism is linked to cell viability might provide new approaches for treatment of cancer.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

In human cells, glucose deprivation killed normal fibroblasts independently of MYC and not by apoptosis, whereas glutamine deprivation induced MYC-dependent apoptosis. The glutamine-dependent death was linked to depletion of Krebs cycle intermediates and was prevented by pyruvate or oxaloacetate, but not by ATP, glutathione, DNA damage, protein synthesis, or mTOR mechanisms.

Key findings

  • Glucose depletion killed IER-MYC human fibroblasts irrespective of ERTM-MYC activity; 0.5 mM glucose (2% of normal) killed more slowly but also independently of MYC. Death was not apoptosis, as shown by absence of chromatin condensation and failure of Bcl-2 to prevent death.
  • Glutamine depletion killed IER-MYC cells faster when ERTM-MYC was active; IER control cells remained viable without glutamine regardless of OHT. Death was apoptosis via the intrinsic pathway: Bcl-2 and caspase-9 dominant-negative prevented death, while crmA had no effect.
  • Apoptosis after glutamine depletion was not caused by ATP deficiency, glutathione deficiency, DNA damage, protein synthesis deficiency, mTOR inhibition, or cell cycle arrest. Glutamine deprivation depleted Krebs cycle intermediates except citrate and isocitrate; pyruvate or oxaloacetate completely prevented apoptosis but did not restore proliferation, and the NADH/NAD ratio remained unchanged.
  • Nutrient requirements varied by cell type: HFF-ER-MYC reacted like IER-MYC; HA1E cells underwent apoptosis after glucose depletion and reacted to glutamine depletion like IER-MYC; RPE-hTERT cells survived without glutamine irrespective of ectopic MYC and died without glucose independently of MYC by a non-apoptotic mechanism.

Methods

  • Normal human fibroblasts IMR90 were retrovirally transduced with ERTM-MYC (IER-MYC) or ERTM alone (IER); HFF, HA1E, and RPE-hTERT cells were also tested. ERTM-MYC was activated with 200 nM 4-hydroxytamoxifen (OHT), with ethanol as vehicle.
  • Nutrient depletion used glucose-free or glutamine-free DMEM; standard concentrations were 10 mM glucose and 2 mM glutamine. Viability and apoptosis were assessed by annexin V/PI, Hoechst 33342 nuclear morphology, Trypan Blue, and immunoblotting/immunofluorescence.
  • Metabolite and viability analyses included ATP by luciferin-luciferase, reduced glutathione by flow cytometry, NADH/NAD by enzymatic cycling, lactate by LDH reaction, and capillary electrophoresis coupled to mass spectrometry (CE-MS) for metabolite profiling. Results are presented as averages of independent experiments with SDs where indicated.

Limitations

  • Stated: how abnormal MYC synergizes with glutamine depletion to induce apoptosis remains to be determined; the authors cannot exclude a combination of tested mechanisms or an unknown glutamine function. Mitochondrial NADH/NAD+ and FADH/FAD+ ratios were not measured.
  • Stated: the effect of nutrient depletion varied across cell types, so conclusions may be difficult to extrapolate from one or a few experimental systems.
  • Evident: the study relies on ectopically expressed inducible ERTM-MYC in cultured human cell lines rather than endogenous MYC or in vivo tumor models; several supporting observations are described as unpublished or are based on two independent experiments.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1083/jcb.200703099

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Glucose deprivation kills human fibroblasts by a process that is different from apoptosis and is largely unaffected by the activity of MYC. (A) IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h. Media was then changed to glucose-free or to media containing 10 mM glucose and the cells were collected at the indicated time to measure cell viability. (B) The experiment was conducted as in A except cells were collected at 12 h (open bars) or 18 h (closed bars) after depletion. (C) IER-MYC cells were incubated as in A for 18 h, fixed, stained with Hoechst 33342, and analyzed by fluorescence microscopy. (D) IER-MYC fibroblasts were transduced with Bcl-2 or vector alone and incubated as in C and analyzed for cell viability by staining with Annexin V-FITC and propidium iodide (PI). Expression of Bcl-2 was confirmed by immunoblotting (not depicted). The averages of three independent experiments are presented in B and D with the error bars representing SDs.
Figure 1. Glucose deprivation kills human fibroblasts by a process that is different from apoptosis and is largely unaffected by the activity of MYC. (A) IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h. Media was then changed to glucose-free or to media containing 10 mM glucose and the cells were collected at the indicated time to measure cell viability. (B) The experiment was conducted as in A except cells were collected at 12 h (open bars) or 18 h (closed bars) after depletion. (C) IER-MYC cells were incubated as in A for 18 h, fixed, stained with Hoechst 33342, and analyzed by fluorescence microscopy. (D) IER-MYC fibroblasts were transduced with Bcl-2 or vector alone and incubated as in C and analyzed for cell viability by staining with Annexin V-FITC and propidium iodide (PI). Expression of Bcl-2 was confirmed by immunoblotting (not depicted). The averages of three independent experiments are presented in B and D with the error bars representing SDs.CC BY-NC-SA · PubMed Central
Figure 2. Glutamine deprivation induces MYC-dependent apoptosis. (A) IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h. Media was then changed to glutamine-free or to media containing 2 mM glutamine, and cells were collected at the indicated times to analyze cell viability. (B and C) IER-MYC were incubated as in A, except without glutamine for 18 h, fixed, stained with Hoechst 33342, visualized by fluorescence microscopy, and cells with condensed chromatin (indicated by white arrows in B) were counted as apoptotic. 200 to 300 nuclei were counted for each sample. The averages of three independent experiments are presented in A and C with errors bars indicating SD. Only MycON cells are shown in B.
Figure 2. Glutamine deprivation induces MYC-dependent apoptosis. (A) IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h. Media was then changed to glutamine-free or to media containing 2 mM glutamine, and cells were collected at the indicated times to analyze cell viability. (B and C) IER-MYC were incubated as in A, except without glutamine for 18 h, fixed, stained with Hoechst 33342, visualized by fluorescence microscopy, and cells with condensed chromatin (indicated by white arrows in B) were counted as apoptotic. 200 to 300 nuclei were counted for each sample. The averages of three independent experiments are presented in A and C with errors bars indicating SD. Only MycON cells are shown in B.CC BY-NC-SA · PubMed Central
Figure 3. Glutamine deprivation induces apoptosis through the intrinsic pathway. (A) IER-MYC cells transduced with Bcl-2 or vector alone were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h, and then for 16 h with or without glutamine before analyzing for cell viability. (B) IER-MYC transduced with C9DN (IER-MYC–C9DN) or with the vector were analyzed as in A. (C) IER-MYC transduced with CrmA or vector alone were treated as in A except anti-Fas (α-CD95) antibody was added as indicated. Each graph represents averages of three independent experiments. Error bars indicate SD.
Figure 3. Glutamine deprivation induces apoptosis through the intrinsic pathway. (A) IER-MYC cells transduced with Bcl-2 or vector alone were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h, and then for 16 h with or without glutamine before analyzing for cell viability. (B) IER-MYC transduced with C9DN (IER-MYC–C9DN) or with the vector were analyzed as in A. (C) IER-MYC transduced with CrmA or vector alone were treated as in A except anti-Fas (α-CD95) antibody was added as indicated. Each graph represents averages of three independent experiments. Error bars indicate SD.CC BY-NC-SA · PubMed Central
Figure 4. Preventing protein synthesis fails to induce apoptosis. (A) Pathways of glutamine metabolism. (B) IER-MYC cells were incubated in the presence of OHT (MYCON) for 24 h. The media was then changed to that deficient in the indicated amino acids and the cells were incubated for 19 h before analyzing their viability. An average of two experiments is shown. (C) IER-MYC were incubated as in B except rapamycin was added as indicated 18 h before analyzing the rate of apoptosis (top panel) and phosphorylation of S6 (bottom panels). One of two independent experiments is shown.
Figure 4. Preventing protein synthesis fails to induce apoptosis. (A) Pathways of glutamine metabolism. (B) IER-MYC cells were incubated in the presence of OHT (MYCON) for 24 h. The media was then changed to that deficient in the indicated amino acids and the cells were incubated for 19 h before analyzing their viability. An average of two experiments is shown. (C) IER-MYC were incubated as in B except rapamycin was added as indicated 18 h before analyzing the rate of apoptosis (top panel) and phosphorylation of S6 (bottom panels). One of two independent experiments is shown.CC BY-NC-SA · PubMed Central
Figure 5. Glutamine depletion induces apoptosis not by causing ATP deficiency. IER-MYC–C9DN cells (A) or IER-MYC cells (B) were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h and then for 18 h in the indicated media before collecting them to measure concentration of ATP (A) or cell viability (B). An average of three independent experiments is presented in A with the error bars representing SD, and an average of two independent experiments in B.
Figure 5. Glutamine depletion induces apoptosis not by causing ATP deficiency. IER-MYC–C9DN cells (A) or IER-MYC cells (B) were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h and then for 18 h in the indicated media before collecting them to measure concentration of ATP (A) or cell viability (B). An average of three independent experiments is presented in A with the error bars representing SD, and an average of two independent experiments in B.CC BY-NC-SA · PubMed Central
Figure 6. Depleting glutathione fails to induce apoptosis. (A) Biosynthesis of glutathione. (B) IER-MYC–C9DN were incubated with OHT (MYCON) or ethanol (MYCOFF) for 24 h, and then transferred to the medium depleted of glutamine or supplemented with 100 μM BSO. Cells were collected at the indicated time to measure reduced glutathione by flow cytometry (Materials and methods). (C) IER-MYC cells were treated as in A except the cells were collected at 24 h of incubation in the indicated media to determine the rate of apoptosis. Shown are the averages of two independent experiments.
Figure 6. Depleting glutathione fails to induce apoptosis. (A) Biosynthesis of glutathione. (B) IER-MYC–C9DN were incubated with OHT (MYCON) or ethanol (MYCOFF) for 24 h, and then transferred to the medium depleted of glutamine or supplemented with 100 μM BSO. Cells were collected at the indicated time to measure reduced glutathione by flow cytometry (Materials and methods). (C) IER-MYC cells were treated as in A except the cells were collected at 24 h of incubation in the indicated media to determine the rate of apoptosis. Shown are the averages of two independent experiments.CC BY-NC-SA · PubMed Central
Figure 7. Glutamine deprivation does not increase p53 concentration. IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h. The cells were then incubated either in the medium that was deficient in glutamine for 24 h, or for 36 h in the complete medium supplemented with DON (A), for 24 h supplemented with 1 mM MMPR (B), or for 18 h supplemented with 100 μM etoposide (C) before determining the rate of apoptosis (graphs) and the concentration of p53 by immunoblotting. The averages of two (A, B) or three (C) independent experiments are shown. Error bars in C are SDs.
Figure 7. Glutamine deprivation does not increase p53 concentration. IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h. The cells were then incubated either in the medium that was deficient in glutamine for 24 h, or for 36 h in the complete medium supplemented with DON (A), for 24 h supplemented with 1 mM MMPR (B), or for 18 h supplemented with 100 μM etoposide (C) before determining the rate of apoptosis (graphs) and the concentration of p53 by immunoblotting. The averages of two (A, B) or three (C) independent experiments are shown. Error bars in C are SDs.CC BY-NC-SA · PubMed Central
Figure 8. Oxaloacetate or pyruvate rescue glutamine-depleted cells from apoptosis but not from cell cycle arrest. (A and B) IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h and then in the indicated media for 18 h before measuring cell viability. An average of three (A) and two (B) independent experiments is presented. Error bars in A indicate SDs. (C) IER-MYC–C9DN cells were incubated with OHT for 24 h. Media was then changed to that containing 2 mM of the indicated supplements and incubated for 24 h in one experiment (filled bars) or 48 h in the second experiment (open bars) before counting the cells. The relative increase in cell number is shown. (D) IER-MYC–C9DN cells were treated either with ethanol or OHT and then incubated with or without glutamine for the indicated time before measuring the NADH to NAD+ ratio. Treatment with rotenon (Rot) was used as a positive control.
Figure 8. Oxaloacetate or pyruvate rescue glutamine-depleted cells from apoptosis but not from cell cycle arrest. (A and B) IER-MYC cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h and then in the indicated media for 18 h before measuring cell viability. An average of three (A) and two (B) independent experiments is presented. Error bars in A indicate SDs. (C) IER-MYC–C9DN cells were incubated with OHT for 24 h. Media was then changed to that containing 2 mM of the indicated supplements and incubated for 24 h in one experiment (filled bars) or 48 h in the second experiment (open bars) before counting the cells. The relative increase in cell number is shown. (D) IER-MYC–C9DN cells were treated either with ethanol or OHT and then incubated with or without glutamine for the indicated time before measuring the NADH to NAD+ ratio. Treatment with rotenon (Rot) was used as a positive control.CC BY-NC-SA · PubMed Central
Figure 9. Glutamine deprivation depletes intermediates of the Krebs cycle. (A) IER-MYC–C9DN cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h and then in the medium with or without glutamine for the indicated time. The cells were then collected at the indicated times to determine the concentration of intracellular metabolites by CE-MS (Materials and methods). Duplicate samples were prepared from independent plates. The result of one experiment is presented. The results of two more independent experiments are presented in Table S1. (B) A guide to the location of identified metabolites in the pathways of glutamine metabolism. The detected metabolites are indicated in red.
Figure 9. Glutamine deprivation depletes intermediates of the Krebs cycle. (A) IER-MYC–C9DN cells were incubated in the presence of OHT (MYCON) or ethanol (MYCOFF) for 24 h and then in the medium with or without glutamine for the indicated time. The cells were then collected at the indicated times to determine the concentration of intracellular metabolites by CE-MS (Materials and methods). Duplicate samples were prepared from independent plates. The result of one experiment is presented. The results of two more independent experiments are presented in Table S1. (B) A guide to the location of identified metabolites in the pathways of glutamine metabolism. The detected metabolites are indicated in red.CC BY-NC-SA · PubMed Central
Figure 10. The effect of MYC on requirements for glutamine and glucose depends on cell type. (A) Normal human foreskin fibroblasts (HFF) transduced with ERTM-MYC (HFFER-MYC) were incubated with either ethanol (MYCOFF) or OHT (MYCON) and then with or without glutamine for 48 h before scoring apoptotic nuclei. An average of two independent experiments is shown. (B) HFFER-MYC cells were incubated as in A, except the medium had no glucose and the viability determined by scoring cells stained with annexin V and PI. (C and D) Immortalized human kidney epithelial cells (HA1E) transduced with MYC-ERTM (HA1EMYC-ER) were incubated and scored for apoptosis as in A either at the indicated time points (C) or after 24 h of glutamine deprivation (D). In D an average of three independent experiments is presented. (E) HA1EMYC-ER were treated and scored for viability as in B. (F) RPE-MYC and RPE-Neo cells were incubated as indicated for 53 h before scoring for apoptosis. An average of three independent experiments is shown with the error bars indicating SDs.
Figure 10. The effect of MYC on requirements for glutamine and glucose depends on cell type. (A) Normal human foreskin fibroblasts (HFF) transduced with ERTM-MYC (HFFER-MYC) were incubated with either ethanol (MYCOFF) or OHT (MYCON) and then with or without glutamine for 48 h before scoring apoptotic nuclei. An average of two independent experiments is shown. (B) HFFER-MYC cells were incubated as in A, except the medium had no glucose and the viability determined by scoring cells stained with annexin V and PI. (C and D) Immortalized human kidney epithelial cells (HA1E) transduced with MYC-ERTM (HA1EMYC-ER) were incubated and scored for apoptosis as in A either at the indicated time points (C) or after 24 h of glutamine deprivation (D). In D an average of three independent experiments is presented. (E) HA1EMYC-ER were treated and scored for viability as in B. (F) RPE-MYC and RPE-Neo cells were incubated as indicated for 53 h before scoring for apoptosis. An average of three independent experiments is shown with the error bars indicating SDs.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

28 Own result · 13 Not checked yet · 11 Own interpretation · 6 Own method

Verify all 18 references — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 15
25 of 25
  • The paper relies on this without support.

    Metabolism can vary among species.

    “Considering that metabolism can vary among species, and that human rather than animal tumors are of primary interest, we used human cells.”
  • The paper relies on this without support.

    Glutamine is made by cells, making the requirement for exogenous glutamine appear unnecessary.

    “However, glutamine is made by cells, which makes the requirement for exogenous glutamine appear unnecessary.”
  • The paper relies on this without support.

    Oxaloacetate is a membrane-permeable Krebs cycle intermediate and pyruvate can enter the Krebs cycle by converting into acetyl-CoA or oxaloacetate.

    “oxaloacetate, which is a membrane-permeable Krebs cycle intermediate, or pyruvate, which can enter the cycle by converting into acetyl-CoA or oxaloacetate, completely prevented apoptosis in the absence of glutamine (Fig. 8, A and B).”
  • The paper relies on this without support.

    Why glutamine is required for cell viability is not entirely clear.

    “Surprisingly, why glutamine is required for cell viability, or, in other words, why depletion of glutamine would kill cells, is not entirely clear.”
  • The paper relies on this without support.

    p53 is mutated in many cancers.

    “which is an advantage as this protein is mutated in many cancers”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 72 references

Research works printed but not linked: 6

  1. 1969, Cancer Res., 29, 669
  2. 1969, Cancer Res., 29, 1195
  3. 1985, Eur. J. Cell Biol., 36, 176
  4. 2004, Anticancer Res., 24, 1121
  5. 2003, Cancer Res., 63, 7330
  6. 1984, Fed. Proc., 43, 121

Cited by

Sorted by citations

See all 692

Metadata

Authors
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y.
Affiliations
  • University of California, San Francisco (US)
  • ETH Zurich (CH)
  • University of Regensburg (DE)
  • Cold Spring Harbor Laboratory (US)
Corresponding author
Lazebnik, Yuri
Venue
The Journal of Cell Biology
Published
2007-07-02
Volume
178
Issue
1
Pages
93-105
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2112861594
Cited by
690
References
72
Citations by year
2026: 16 · 2025: 27 · 2024: 26 · 2023: 46 · 2022: 36 · 2021: 36 · 2020: 32 · 2019: 40 · 2018: 39 · 2017: 56 · 2016: 49 · 2015: 47 · 2014: 50 · 2013: 46 · 2012: 42
FWCI
7.28
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
Funders
National Cancer Institute (CA-13106-31, P01CA013106)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
glutamine deprivation, glucose deprivation, c-Myc, apoptosis, Krebs cycle intermediates, nutrient deprivation, cancer therapy, glutamine metabolism, cell viability, glucose metabolism
MeSH terms
Proto-Oncogene Mas, Cell Line, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Glucose, Glutamine, Humans, Lung, Male, Retroviridae, Skin, Transduction, Genetic, Proto-Oncogene Proteins c-myc, Apoptosis, Cell Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review